Nathan Beals

Nathan Beals is a highly skilled biotechnology consultant currently working at Nodes Advisors AG, where responsibilities include assessing technologies of portfolio companies and sourcing partnerships to enhance clinical applications of biotechnology assets. In addition to this role, Nathan serves as a technical consultant for Tezcat Biosciences, collaborating closely with the CEO and CSO on protein-drug conjugates developed from patented technologies in the Bar-Sagi lab. As a postdoctoral researcher at NYU Langone Health, Nathan focuses on exploring the relationship between nanomaterials and macropinocytosis, developing biological drug delivery systems for mutant RAS cancers, immunomodulation, and drug escape mechanisms. Previous research experience includes a role at Kent State University, where investigations centered on nucleic acids and nanomaterials to advance therapeutic strategies for various diseases. Nathan holds a Ph.D. in Biochemistry from Kent State University and dual bachelor's degrees in Chemistry and Psychology from Case Western Reserve University.